following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
the report called this �one of the most significant perils to humans resulting from human activity.�.
lawmakers should revisit that idea when lepage is no longer in office next year..